Participants will have a stronger strategy for tackling oncology studies that will keep their trials running in the post-pandemic environment.
TORONTO (PRWEB) April 06, 2021
The COVID pandemic has had a tremendous impact on clinical development. This is reflected in a decrease in the number of new oncology clinical trials launched, as well as a drop in the number of patients who enrolled in trials. The conduct of oncology clinical trials changed as well, pivoting to ensure the safety of patients, clinical researchers and staff, and adjusting for major travel restrictions. However, the disruption resulted in the opportunity for a change in how clinical trials are conducted – a change that had been long discussed but not put into action. How will oncology clinical trials be strengthened as a result?
After the webinar, participants will have a stronger strategy for tackling oncology studies that will keep their trials running in the post-pandemic environment.
For more information, or to register for this event, visit Forward-Focused Oncology: Applying Lessons Learned from COVID to Strengthen Oncology Clinical Trials.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.